Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has results × rrCLL × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 313 Carcinoma, Non-Small-Cell Lung 159 Breast Neoplasms 124 Neoplasm Metastasis 102 Melanoma 92 Lymphoma 79 Leukemia, Myeloid, Acute 79 Multiple Myeloma 73 Colorectal Neoplasms 71 Ovarian Neoplasms 68 Lymphoma, Non-Hodgkin 63 Recurrence 58 Prostatic Neoplasms 52 Pancreatic Neoplasms 49 Lung Neoplasms 47 Carcinoma, Renal Cell 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 37 Leukemia, Lymphocytic, Chronic, B-Cell 37 Glioblastoma 36 Advanced Solid Tumors 36 Leukemia 35 Myelodysplastic Syndromes 34 Triple Negative Breast Neoplasms 33 Head and Neck Neoplasms 32 Sarcoma 30 Brain Neoplasms 30 Urinary Bladder Neoplasms 29 Stomach Neoplasms 29 Lymphoma, Follicular 28

Interventions

pembrolizumab 1 dinaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02684617 2021-03-01

KEYNOTE-155

Merck Sharp & Dohme LLC

Phase 1 Terminated

75 enrolled 17 charts

rrCLL

Data powered by HemOnc (CC BY 4.0) Colophon ⚡